• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS27
Device Problem Material Too Rigid or Stiff (1544)
Patient Problems Aortic Valve Stenosis (1717); Thrombosis (2100)
Event Type  Death  
Event Description
The manufacturer was notified that a patient received a perceval pvs27 in 2018.In (b)(6) of 2020 the patient was identified to potential thrombosis with a high gradient.They were indicated for a redo avr and cabg on (b)(6) 2020.On (b)(6) 2020 the patient had taken/been given plavix and was being rescheduled for monday.The patient condition worsened and was taken to the operating room.The patient was given chest compression's on the operating room table as the staff tried to prep them and cannulate femoral.Patient heart rate was established via heart compression's.The chest was opened and the site attempted to resolve bleeding issues and adhesion's.The aorta was not opened.The patient passed away and the valve was never explanted.No further details were received.
 
Manufacturer Narrative
The manufacturer made several attempts to follow-up for further information related to the specific event details and no further information was received.At this time since no further information regarding the root cause is available and the device was not explanted no further investigations can be performed.Because of the limited information surrounding the device functionality over time, patient factors, and correlation between the thrombosis and the adverse event the root cause cannot be established at this time.However, should additional information be provided, the manufacturer will re-assess the event and take further investigative action as applicable.It should be noted the device history record confirmed the device met all required standards at the time of manufacture and release.
 
Manufacturer Narrative
The manufacturer determined the device serial number through the patient tracking database.The sn has been included in section d.The manufacturing and material records for the perceval heart valve, model #icv1211 , s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by quality engineering at livanova canada corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1211) perceval heart valve at the time of manufacture and release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
MDR Report Key10486087
MDR Text Key205451412
Report Number1718850-2020-01127
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup,Followup
Report Date 08/06/2020,10/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/20/2021
Device Model NumberPVS27
Device Catalogue NumberICV1211
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/23/2020
Device Age34 MO
Event Location Hospital
Date Report to Manufacturer08/06/2020
Date Manufacturer Received08/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-